Selective Mitochondrial Uptake of MKT-077 Can Suppress Medullary Thyroid Carcinoma Cell Survival In Vitro and In Vivo
about
Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells.Suppression of B-RafV600E melanoma cell survival by targeting mitochondria using triphenyl-phosphonium-conjugated nitroxide or ubiquinone.Mitochondria chaperone GRP75 moonlighting as a cell cycle controller to derail endocytosis provides an opportunity for nanomicrosphere intracellular delivery.Targeted Therapy for Medullary Thyroid Cancer: A Review.Mitochondrial autophagosomes as a mechanism of drug resistance in breast carcinoma.
P2860
Selective Mitochondrial Uptake of MKT-077 Can Suppress Medullary Thyroid Carcinoma Cell Survival In Vitro and In Vivo
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Selective Mitochondrial Uptake ...... Survival In Vitro and In Vivo
@ast
Selective Mitochondrial Uptake ...... Survival In Vitro and In Vivo
@en
type
label
Selective Mitochondrial Uptake ...... Survival In Vitro and In Vivo
@ast
Selective Mitochondrial Uptake ...... Survival In Vitro and In Vivo
@en
prefLabel
Selective Mitochondrial Uptake ...... Survival In Vitro and In Vivo
@ast
Selective Mitochondrial Uptake ...... Survival In Vitro and In Vivo
@en
P2860
P1476
Selective Mitochondrial Uptake ...... Survival In Vitro and In Vivo
@en
P2093
Dmytro Starenki
P2860
P304
P356
10.3803/ENM.2015.30.4.593
P50
P577
2015-10-20T00:00:00Z